Nutex Health (NASDAQ:NUTX) Stock Price Down 7% – Time to Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s stock price traded down 7% during trading on Wednesday . The stock traded as low as $174.00 and last traded at $174.7370. Approximately 34,873 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 178,596 shares. The stock had previously closed at $187.90.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. B. Riley Financial began coverage on Nutex Health in a research report on Friday, June 26th. They set a “buy” rating and a $290.00 price target on the stock. Zacks Research upgraded Nutex Health to a “hold” rating in a report on Monday, June 29th. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Finally, Lake Street Capital initiated coverage on Nutex Health in a research note on Tuesday, June 2nd. They set a “buy” rating and a $235.00 target price for the company. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Nutex Health has a consensus rating of “Moderate Buy” and a consensus price target of $243.33.

Nutex Health Stock Down 6.4%

The stock has a market cap of $1.21 billion, a P/E ratio of 13.58 and a beta of 0.21. The firm has a 50 day simple moving average of $140.34 and a 200-day simple moving average of $130.53. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66.

Nutex Health (NASDAQ:NUTX) last posted its earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.The business had revenue of $216.49 million for the quarter, compared to analyst estimates of $227.80 million. On average, equities research analysts forecast that Nutex Health Inc. will post 22.72 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nutex Health

Institutional investors and hedge funds have recently modified their holdings of the stock. Islay Capital Management LLC acquired a new stake in shares of Nutex Health during the 4th quarter worth about $34,000. BNP Paribas Financial Markets grew its stake in Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after buying an additional 290 shares during the last quarter. Royal Bank of Canada raised its holdings in Nutex Health by 752.4% in the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after acquiring an additional 316 shares during the period. Osaic Holdings Inc. raised its holdings in Nutex Health by 280.3% in the 4th quarter. Osaic Holdings Inc. now owns 810 shares of the company’s stock valued at $133,000 after acquiring an additional 597 shares during the period. Finally, EverSource Wealth Advisors LLC acquired a new stake in Nutex Health during the first quarter worth approximately $83,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.